Works matching IS 00070920 AND DT 2025 AND VI 132 AND IP 1

Results: 14

Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic review: Clinical Studies.

Published in:

British Journal of Cancer, 2025, v. 132, n. 1, p. 49, doi. 10.1038/s41416-024-02933-y

By:

Villa, Alessandro;
Schneider, Bryan J.;
Lacchetti, Christina;
Oliver, Thomas K.;
Peterson, Douglas E.

Publication type:

Article

Correction: Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review.

Published in:

2025

By:

Jayathilaka, Bishma;
Mian, Farah;
Franchini, Fanny;
Au-Yeung, George;
IJzerman, Maarten

Publication type:

Correction Notice

Editorial Expression of Concern: Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model.

Published in:

British Journal of Cancer, 2025, v. 132, n. 1, p. 138, doi. 10.1038/s41416-024-02918-x

By:

Kususda, Y.;
Miyake, H.;
Gleave, M. E.;
Fujisawa, M.

Publication type:

Article

Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trial: Clinical Studies.

Published in:

British Journal of Cancer, 2025, v. 132, n. 1, p. 58, doi. 10.1038/s41416-024-02913-2

By:

Noronha, Vanita;
Menon, Nandini;
Patil, Vijay M.;
Shah, Minit;
Joshi, Amit;
Shah, Srushti;
Nawale, Kavita;
Surve, Rohan;
Bafna, Gunj;
Jogdhankar, Shweta;
Shelar, Priyanka;
Shetake, Ankush;
Singh, Ashish;
Salian, Sushmita;
Jadhav, Pundlik;
Shah, Hetakshi;
Mer, Neha;
Vohra, Ananya;
Majumdar, Swaratika;
Banavali, Shripad

Publication type:

Article

SKP2 inhibition activates tumor cell-intrinsic immunity by inducing DNA replication stress and genomic instability: Cellular and Molecular Biology.

Published in:

British Journal of Cancer, 2025, v. 132, n. 1, p. 81, doi. 10.1038/s41416-024-02909-y

By:

Peng, Yuchong;
Qi, Xuli;
Ding, Liuyang;
Huang, Jingjing;
Liu, Youhong;
Zheng, Rirong;
Fu, Yongming;
Yin, Linglong;
Deng, Tanggang;
Ye, Yubing;
Chen, Size;
Li, Xiong

Publication type:

Article

Associations of blood lipids and LDL cholesterol lowering drug-targets with colorectal cancer risk: a Mendelian randomisation study: Epidemiology.

Published in:

British Journal of Cancer, 2025, v. 132, n. 1, p. 103, doi. 10.1038/s41416-024-02900-7

By:

Chan, Wing Ching;
Liu, Lili;
Bouras, Emmanouil;
Zuber, Verena;
Wen, Wanqing;
Long, Jirong;
Gill, Dipender;
Murphy, Neil;
Gunter, Marc J.;
Assimes, Themistocles L.;
Bujanda, Luis;
Gruber, Stephen B.;
Küry, Sébastien;
Lynch, Brigid M.;
Qu, Conghui;
Thomas, Minta;
White, Emily;
Woods, Michael O.;
Peters, Ulrike;
Li, Christopher I.

Publication type:

Article

Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort study: Epidemiology.

Published in:

British Journal of Cancer, 2025, v. 132, n. 1, p. 93, doi. 10.1038/s41416-024-02895-1

By:

Hektoen, Helga H.;
Tsuruda, Kaitlyn M.;
Fjellbirkeland, Lars;
Nilssen, Yngvar;
Brustugun, Odd Terje;
Andreassen, Bettina K.

Publication type:

Article

Integrated proteomics and scRNA-seq analyses of ovarian cancer reveal molecular subtype-associated cell landscapes and immunotherapy targets: Molecular Diagnostics.

Published in:

British Journal of Cancer, 2025, v. 132, n. 1, p. 111, doi. 10.1038/s41416-024-02894-2

By:

Tan, Rong;
Wen, Ming;
Yang, Wenqing;
Zhan, Dongdong;
Zheng, Nairen;
Liu, Mingwei;
Zhu, Fang;
Chen, Xiaodan;
Wang, Meng;
Yang, Siyu;
Xie, Bin;
He, Qiongqiong;
Yuan, Kai;
Sun, Lunquan;
Wang, Yi;
Qin, Jun;
Zhang, Yu

Publication type:

Article

IL-10RA governor the expression of IDO in the instruction of lymphocyte immunity: Translational Therapeutics.

Published in:

British Journal of Cancer, 2025, v. 132, n. 1, p. 126, doi. 10.1038/s41416-024-02893-3

By:

Tai, Tzong-Shyuan;
Hsu, Duen-Wei;
Yang, Yu-Shao;
Tsai, Ching-Yen;
Shi, Jai-Wen;
Wu, Chien-Hui;
Hsu, Shu-Ching

Publication type:

Article

VEGF-C propagates 'onward' colorectal cancer metastasis from liver to lung: Cellular and Molecular Biology.

Published in:

British Journal of Cancer, 2025, v. 132, n. 1, p. 69, doi. 10.1038/s41416-024-02892-4

By:

Poghosyan, Susanna;
Frenkel, Nicola;
van den Bent, Lotte;
Raats, Danielle;
Spaapen, Tessa;
Laoukili, Jamila;
Borel Rinkes, Inne;
Kranenburg, Onno;
Hagendoorn, Jeroen

Publication type:

Article

Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review: Epidemiology.

Published in:

British Journal of Cancer, 2025, v. 132, n. 1, p. 51, doi. 10.1038/s41416-024-02887-1

By:

Jayathilaka, Bishma;
Mian, Farah;
Franchini, Fanny;
Au-Yeung, George;
IJzerman, Maarten

Publication type:

Article

UK guidelines for the management of bone sarcomas: Clinical Studies.

Published in:

British Journal of Cancer, 2025, v. 132, n. 1, p. 32, doi. 10.1038/s41416-024-02868-4

By:

Gerrand, Craig;
Amary, Fernanda;
Anwar, Hanny A.;
Brennan, Bernadette;
Dileo, Palma;
Kalkat, Maninder Singh;
McCabe, Martin G.;
McCullough, Anna Louise;
Parry, Michael C.;
Patel, Anish;
Seddon, Beatrice M.;
Sherriff, Jennifer M.;
Tirabosco, Roberto;
Strauss, Sandra J.

Publication type:

Article

UK guidelines for the management of soft tissue sarcomas: Clinical Studies.

Published in:

British Journal of Cancer, 2025, v. 132, n. 1, p. 11, doi. 10.1038/s41416-024-02674-y

By:

Hayes, Andrew J.;
Nixon, Ioanna F.;
Strauss, Dirk C.;
Seddon, Beatrice M.;
Desai, Anant;
Benson, Charlotte;
Judson, Ian R.;
Dangoor, Adam

Publication type:

Article

Gastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelines: Clinical Studies.

Published in:

British Journal of Cancer, 2025, v. 132, n. 1, p. 1, doi. 10.1038/s41416-024-02672-0

By:

Judson, Ian;
Jones, Robin L.;
Wong, Newton A. C. S.;
Dileo, Palma;
Bulusu, Ramesh;
Smith, Myles;
Almond, Max

Publication type:

Article